1. Vascular risk factor control and adherence to secondary preventive medication after ischaemic stroke
- Author
-
Torunn Askim, Mona K. Beyer, Yngve Müller Seljeseth, Halvor Naess, Anne Brita Knapskog, Tove Røsstad, Rachel Aakerøy, Ingvild Saltvedt, Pernille Thingstad, Hege Ihle-Hansen, Mari Nordbø Gynnild, Stian Lydersen, Ragnhild Munthe-Kaas, Hanne Ellekjær, and Olav Spigset
- Subjects
Male ,0301 basic medicine ,medicine.medical_specialty ,030204 cardiovascular system & hematology ,Medication Adherence ,Persistence (computer science) ,03 medical and health sciences ,0302 clinical medicine ,Risk Factors ,Internal medicine ,Secondary Prevention ,Internal Medicine ,medicine ,Humans ,Risk factor ,Stroke ,Aged ,Ischemic Stroke ,Polypharmacy ,Norway ,business.industry ,Age Factors ,medicine.disease ,030104 developmental biology ,Blood pressure ,Medication Persistence ,Female ,Observational study ,business - Abstract
Background Studies regarding adequacy of secondary stroke prevention are limited. We report medication adherence, risk factor control and factors influencing vascular risk profile following ischaemic stroke. Methods A total of 664 home‐dwelling participants in the Norwegian Cognitive Impairment After Stroke study, a multicenter observational study, were evaluated 3 and 18 months poststroke. We assessed medication adherence by self‐reporting (4‐item Morisky Medication Adherence Scale) and medication persistence (defined as continuation of medication(s) prescribed at discharge), achievement of guideline‐defined targets of blood pressure (BP) (
- Published
- 2020